Spotlighting the most promising biotechnology companies in Israel.

Although it is a smaller country, Israel’s biotechnology sector is flourishing. According to Ernst & Young, BioIsrael has recently experienced a boost of venture capital placing it among the ranks of larger biotech companies. With more capital, IsraelBio has been able to increase the number of products within Phase III development. IsraelBio also boasts a large number of students and graduates in life sciences, showing promise for future growth and development.


Hotbed News
10 Biotech Stocks Analysts are Upbeat About in May Monday, May 23, 2016
Oramed (ORMP)'s Oral Insulin Succeeds In Phase IIb Type 2 Diabetes Trial Thursday, May 19, 2016
Acadia (ACAD) Drug Approval May Make It an Attractive Target for Biogen (BIIB), Teva (TEVA) Tuesday, May 10, 2016
Eli Lilly (LLY) and Regeneron (REGN): How to Find Your First Biopharma Job Right Out of College Friday, May 20, 2016
Teva (TEVA)'s European Portfolio Attracts Interest from Mylan (MYL) and Novartis AG (NVS), Sale Could Bring in $1.5 to $2 Billion Tuesday, May 17, 2016
Life Science Ranks Among Top 9 College Majors to Get a Job Thursday, May 05, 2016
The Highest Paying Life Sciences Jobs Friday, April 22, 2016
10 Best U.S. States for Working Moms Friday, May 06, 2016
BioPharm Executive: Biotech Is for the 1% Friday, April 29, 2016
Kitov (KTOV) Receives Pre-NDA Meeting Response From FDA For KIT-302, Supporting Its NDA Submission Thursday, May 12, 2016